Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Trends in Pharmacological Sciences|August 5, 2023
Calcitonin/PAC1 receptor splice variants: a blind spot in migraine researchTayla A Rees, Alejandro Labastida-Ramírez, Eloisa Rubio-BeltránThe Journal of Headache and Pain|August 9, 2018
PACAP38 and PAC1 receptor blockade: a new target for headache?Eloisa Rubio-Beltrán, Edvige Correnti, Marie Deen, et al.The Journal of Headache and Pain|July 3, 2026
Trigeminovascular calcitonin gene-related peptide release and peripheral vascular responses in a mouse model of accelerated aging: Implications for migraineLinda Al-Hassany, Eloisa Rubio-Beltrán, Alejandro Labastida-Ramirez, et al.Cephalalgia : an International Journal of Headache|May 21, 2019
Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine modelsKristian A Haanes, Alejandro Labastida-Ramírez, Frank W Blixt, et al.The Journal of Headache and Pain|September 27, 2017
Blocking CGRP in migraine patients - a review of pros and consMarie Deen, Edvige Correnti, Katharina Kamm, et al.The Journal of Headache and Pain|January 3, 2025
Influence of next-generation artificial intelligence on headache research, diagnosis and treatment: the junior editorial board members' vision - part 2Igor Petrušić, Chia-Chun Chiang, David Garcia-Azorin, et al.American Journal of Physiology. Renal Physiology|February 15, 2021
Dietary salt modifies the blood pressure response to renin-angiotensin inhibition in experimental chronic kidney diseaseDominique M Bovée, Estrellita Uijl, David Severs, et al.The Journal of Headache and Pain|December 5, 2024
Combining treatments for migraine prophylaxis: the state-of-the-artLanfranco Pellesi, David Garcia-Azorin, Eloisa Rubio-Beltrán, et al.Clinical Science (London, England : 1979)|March 24, 2020
Local endothelial DNA repair deficiency causes aging-resembling endothelial-specific dysfunctionPaula K Bautista-Niño, Eliana Portilla-Fernandez, Eloisa Rubio-Beltrán, et al.Pageof 1